Literature DB >> 34104420

Optimizing the diagnosis and assessment of chronic thromboembolic pulmonary hypertension with advancing imaging modalities.

Seth Kligerman1, Albert Hsiao1.   

Abstract

Imaging is key to nearly all aspects of chronic thromboembolic pulmonary hypertension including management for screening, assessing eligibility for pulmonary endarterectomy, and post-operative follow-up. While ventilation/perfusion scintigraphy, the gold standard technique for chronic thromboembolic pulmonary hypertension screening, can have excellent sensitivity, it can be confounded by other etiologies of pulmonary malperfusion, and does not provide structural information to guide operability assessment. Conventional computed tomography pulmonary angiography has high specificity, though findings of chronic thromboembolic pulmonary hypertension can be visually subtle and unrecognized. In addition, computed tomography pulmonary angiography can provide morphologic information to aid in pre-operative workup and assessment of other structural abnormalities. Advances in computed tomography imaging techniques, including dual-energy computed tomography and spectral-detector computed tomography, allow for improved sensitivity and specificity in detecting chronic thromboembolic pulmonary hypertension, comparable to that of ventilation/perfusion scans. Furthermore, these advanced computed tomography techniques, compared with conventional computed tomography, provide additional physiologic data from perfused blood volume maps and improved resolution to better visualize distal chronic thromboembolic pulmonary hypertension, an important consideration for balloon pulmonary angioplasty for inoperable patients. Electrocardiogram-synchronized techniques in electrocardiogram-gated computed tomography can also show further information regarding right ventricular function and structure. While the standard of care in the workup of chronic thromboembolic pulmonary hypertension includes a ventilation/perfusion scan, computed tomography pulmonary angiography, direct catheter angiography, echocardiogram, and coronary angiogram, in the future an electrocardiogram-gated dual-energy computed tomography angiography scan may enable a "one-stop" imaging study to guide diagnosis, operability assessment, and treatment decisions with less radiation exposure and cost than traditional chronic thromboembolic pulmonary hypertension imaging modalities.
© The Author(s) 2021.

Entities:  

Keywords:  chronic thromboembolic disease pulmonary hypertension (CTEPH); computed tomography pulmonary angiography (CTPA); dual-energy computed tomography (DECT); imaging; ventilation/perfusion (V/Q) scan

Year:  2021        PMID: 34104420      PMCID: PMC8150458          DOI: 10.1177/20458940211007375

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  69 in total

1.  Don't bury the V/Q scan: it's as good as multidetector CT angiograms with a lot less radiation exposure.

Authors:  Leonard M Freeman
Journal:  J Nucl Med       Date:  2007-12-12       Impact factor: 10.057

2.  Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertension.

Authors:  F N Rahaghi; J C Ross; M Agarwal; G González; C E Come; A A Diaz; G Vegas-Sánchez-Ferrero; A Hunsaker; R San José Estépar; A B Waxman; G R Washko
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

3.  Dual-energy CT angiography of chronic thromboembolic disease: can it help recognize links between the severity of pulmonary arterial obstruction and perfusion defects?

Authors:  Benoit Renard; Martine Remy-Jardin; Teresa Santangelo; Jean-Baptiste Faivre; Nunzia Tacelli; Jacques Remy; Alain Duhamel
Journal:  Eur J Radiol       Date:  2010-05-21       Impact factor: 3.528

Review 4.  Understanding and preventing contrast-induced acute kidney injury.

Authors:  Michael Fähling; Erdmann Seeliger; Andreas Patzak; Pontus B Persson
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

5.  "High probability" perfusion lung scans in pulmonary venoocclusive disease.

Authors:  C L Bailey; R N Channick; W R Auger; P F Fedullo; K M Kerr; G L Yung; L J Rubin
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

6.  C-Arm Computed Tomography Adds Diagnostic Information in Patients with Chronic Thromboembolic Pulmonary Hypertension and a Positive V/Q SPECT.

Authors:  Jan B Hinrichs; Thomas Werncke; Till Kaireit; Marius M Hoeper; Karen M Olsson; Jan-Christopher Kamp; Frank K Wacker; Frank Bengel; Christian von Falck; Imke Schatka; Bernhard C Meyer
Journal:  Rofo       Date:  2016-10-26

Review 7.  Diagnostic Evaluation of Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Deepa Gopalan; Daniel Blanchard; William R Auger
Journal:  Ann Am Thorac Soc       Date:  2016-07

8.  Role of 320-slice CT imaging in the diagnostic workup of patients with chronic thromboembolic pulmonary hypertension.

Authors:  Toshihiko Sugiura; Nobuhiro Tanabe; Yukiko Matsuura; Ayako Shigeta; Naoko Kawata; Takayuki Jujo; Noriyuki Yanagawa; Seiichiro Sakao; Yasunori Kasahara; Koichiro Tatsumi
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

9.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; David Montani; David S Celermajer; Christopher P Denton; Michael A Gatzoulis; Michael Krowka; Paul G Williams; Rogerio Souza
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

Review 10.  Clinical Applications of Wide-Detector CT Scanners for Cardiothoracic Imaging: An Update.

Authors:  Eun Ju Kang
Journal:  Korean J Radiol       Date:  2019-12       Impact factor: 3.500

View more
  1 in total

Review 1.  Chronic thromboembolic pulmonary hypertension: diagnosis, operability assessment and patient selection for pulmonary endarterectomy.

Authors:  Tom Verbelen; Laurent Godinas; Geert Maleux; Johan Coolen; Guido Claessen; Catharina Belge; Bart Meyns; Marion Delcroix
Journal:  Ann Cardiothorac Surg       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.